New autism therapy works in adult mice and human brain organoids, study finds

Blocking the glycine transporter SLC6A20 restored key brain signaling and improved social, communication and repetitive behaviors in autism-related mouse models. The treatment also worked in human brain organoids and showed lasting effects in adult mice. Researchers say the findings suggest the brain may remain more treatable later in life than previously believed.

Similar stories

🔬 Science Single rapamycin dose reversed autism-like symptoms in mice within hours Science Daily · 13d ago 🏥 Health White House prepares order linking childhood vaccines to autism despite advisers' warnings The Independent World · 4h ago 🔬 Science Study of 10 million siblings links birth order to ADHD and autism risk ScienceAlert · 13h ago